Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study - Wikidata - awgldk - TriplyDB

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study

http://www.wikidata.org/entity/Q37132295

about

Future pharmacological treatments for substance use disorders Addiction science: Uncovering neurobiological complexity Genomic analysis to guide choice of treatment for smoking cessation The effect of tobacco cessation on weight gain, obesity, and diabetes risk Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls A review of pharmacogenetic studies of substance-related disorders Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.The association between changes in alternative reinforcers and short-term smoking cessation.The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race.Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review.Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence.Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion.Pathways to precision medicine in smoking cessation treatments.Pharmacogenetic Optimization of Smoking Cessation Treatment.Nicotine dependence as a moderator of a quitline-based message framing intervention.Associations of CYP2A6 genotype with smoking behaviors in southern China.Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.Long-term nicotine replacement therapy: a randomized clinical trial.Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.Biomarkers to optimize the treatment of nicotine dependence.Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.Smokescreen: a targeted genotyping array for addiction research Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.Reproducibility of the nicotine metabolite ratio in cigarette smokers.Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism

P2860

Q22242633-99DC311A-16B2-4115-AECA-E7A025A765F9 Q22251251-28A27246-0853-4FA9-B4C3-FD4D1B555396 Q24188234-FF38D874-1EE1-44E9-9C79-E5A988B83FEA Q26738577-2F74BF0B-EB9A-464F-A031-CD4A958F5375 Q26853551-2EBF1554-7016-490E-9790-B083D4DB89F8 Q27312296-986A87B7-BB58-415C-8A5A-B4A0289D8734 Q27690906-C3CB5335-2690-4447-AD36-A5001248CCCE Q30434359-44960103-7382-4C09-8C0D-3392723796E5 Q33458739-5F8E8FBA-1939-449A-ACD5-B634A8731181 Q33648645-6A11A6EA-BC0C-45A5-8FB0-34C8EC712DD5 Q33693188-4C01BE3F-EDD2-4B2C-AA0F-41467D4F4590 Q33821233-4A543FB4-C40A-4DE7-8B03-449712B2F28A Q34135377-7EE26534-315C-4386-B358-7E819D271BEA Q34270526-C58D6EA3-2890-4947-98AE-6B6E12E94364 Q34277864-5E54AFA6-DAD7-42C9-B83D-CBE78EEF8B59 Q34390412-FCE4B2CC-9CD5-4501-969D-3D3DB9F8149C Q34468802-B61F5D2A-9A79-414D-869A-130B450D4B47 Q34527740-21465E65-5210-4EF7-BB45-4B98F67B88A2 Q34542169-E21840F0-E179-4F42-BC9C-1523504C112E Q34605163-A0FCB484-C6A1-4A0D-89B3-0484CD6E0F36 Q34778875-F5DB336F-1574-4724-9CA4-78BCD9170BF0 Q34799785-BE7C343C-D72F-4671-AC7D-27352671AA05 Q35012346-C9B0F1DF-A30B-4B03-BA5D-6D5F1B169C79 Q35059965-72A14B9B-F984-40BE-A549-EE7E184E8FA3 Q35099123-C9A75390-9C29-439A-BF35-3E193F91F664 Q35541820-AF103530-00B6-43DB-9CC6-FBA7EFA8C572 Q35588731-E4CC33CD-8724-4E71-A698-5CBEDD6DE52D Q35751986-7E8860A8-89DF-4A88-83EC-C3C785789C9E Q35773685-6C2AE41A-9862-4B67-A534-233841B0EA36 Q35782141-E0B2FC4C-3169-4A90-9104-5C9A9BE5C05B Q35788753-CBFEB08E-3507-4940-8939-B6C326CA8AA7 Q35892758-BC4FD093-C297-4006-B1CB-70F7B2A0149A Q35920608-5D686D27-5D77-4739-BB0B-0BDE12D174D6 Q35938102-A5F70524-9E8E-4840-B634-398B5BFFE53D Q35974715-80CDEE2E-2099-4F14-BD09-4148743D715F Q35974959-C0A026EA-DD3A-472C-8896-FE703F0B63AA Q36021256-67AA3FC3-5A6A-4086-A42B-8E8B87BF9618 Q36084196-1285573E-BD8B-40B5-B330-E5C8713C47CE Q36252716-1315BE9D-EE23-47AA-BFC1-3B8FB830F2EB Q36283969-D2E1662E-1FD5-492A-8856-E9251436EA15

P2860

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study

http://www.wikidata.org/entity/Q37132295

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nicotine metabolic rate predic ...... l nicotine: a validation study

@en

Nicotine metabolic rate predic ...... nicotine: a validation study.

@nl

type

label

Nicotine metabolic rate predic ...... l nicotine: a validation study

@en

Nicotine metabolic rate predic ...... nicotine: a validation study.

@nl

prefLabel

Nicotine metabolic rate predic ...... l nicotine: a validation study

@en

Nicotine metabolic rate predic ...... nicotine: a validation study.

@nl

P1433

Q37132295-9C4C2EC6-4CF0-4034-997D-AA56CEE516A3

P1476

Q37132295-E52ABE99-547C-4EBA-BE90-12011F210A39

P2093

Q37132295-0A768EDE-C432-4A71-9188-F0932883816B

Q37132295-6E499BB6-58A8-473F-8EAA-A2F8F460F281

Q37132295-86FDFA02-9817-40AC-B34B-CA30D31B5EBB

Q37132295-A70FCC2A-0E62-4782-B5AC-3473D9C20FF2

Q37132295-A8801BAF-E722-48A8-B97B-1E28156CFFCF

P2860

Q37132295-0D3B96D4-B822-41F0-A85B-C5029F10A970

Q37132295-0E340534-1A81-41D3-B899-45275C1E5F40

Q37132295-18C054D3-3EEF-4658-9132-0634816A2640

Q37132295-420DF40F-7000-4C5E-BFBB-42DB89986DBE

Q37132295-44136657-E88F-4D08-90B8-17E090AAE5E0

Q37132295-4B5BFFD5-707F-47B4-B0B6-8F8E6D0139AC

Q37132295-4FA9211B-345C-4E61-BB66-DD55A74C7154

Q37132295-60C94E72-BEEB-4AE0-803C-10764769406F

Q37132295-81EAEFCC-1148-44D0-801C-21E454F1E16E

Q37132295-9D670B01-5E2B-42BB-ADD1-B18C06BCE1F2

P304

Q37132295-A3C39D5D-74C4-41B0-B029-76CF0BBDDCAB

P31

Q37132295-96823E12-9998-4DC5-8472-1BFD2F7E5388

P356

Q37132295-95F3F012-3A33-43CA-B285-BF4B1F8BEA5D

P407

Q37132295-AF789E84-98E8-4305-9345-82112B7FE9D9

P433

Q37132295-9DC50690-BEC1-4958-A6E0-AE75A74CE5A9

P478

Q37132295-9DE8A0B9-0A2E-4CF2-8EA3-15322A4CE79B

P50

Q37132295-7A7EEDB9-A6DE-42E7-854A-5719492A5195

P577

Q37132295-CCAF2EF4-4F97-4F65-98C4-B3054CE03DE0

P698

Q37132295-59376DA9-2BE5-44B7-AC2B-ADB01E4A90A7

P932

Q37132295-C4F8DC3F-BD80-41A7-A18C-AA4BDBEDA37D

P356

J.PBB.2008.10.016

P1433

Pharmacology, Biochemistry and Behavior

P1476

Nicotine metabolic rate predic ...... l nicotine: a validation study

@en

P2093

E Paul Wileyto

http://www.w3.org/2001/XMLSchema#string

Freda Patterson

http://www.w3.org/2001/XMLSchema#string

Neal Benowitz

http://www.w3.org/2001/XMLSchema#string

Rachel F Tyndale

http://www.w3.org/2001/XMLSchema#string

Robert A Schnoll

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine replacement therapy for smoking cessation

Development and validation of brief measures of positive and negative affect: the PANAS scales

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Individual differences in preferences for and responses to four nicotine replacement products.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Female sex and oral contraceptive use accelerate nicotine metabolism.

The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.

Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers

Sex differences in long-term smoking cessation rates due to nicotine patch.

P304

6-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PBB.2008.10.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19000709

http://www.w3.org/2001/XMLSchema#string

P932

2657225

http://www.w3.org/2001/XMLSchema#string